Sai Parenteral's Limited (SAIPARENT) Share Price
NSE · Healthcare · Drug Manufacturers - General · ISIN INE0H9F01037
Key metrics
- Market Cap
- ₹2,285 Cr
- P/E Ratio
- 116.76
- EPS
- 4.43
- Book Value
- 27.98
- P/B Ratio
- 18.49
- ROE
- 15.88%
- ROCE
- 9.66%
- Debt / Equity
- 1.65
- Net Margin
- 3.97%
- Revenue Growth
- 221.9%
- Profit Growth
- 133.26%
- Dividend Yield
- —
- 52W High
- ₹706.00
- 52W Low
- ₹400.00
- Market Cap Band
- small cap
- Face Value
- 5
Ratios computed from the annual results period ending 2025-03-31.
About Sai Parenteral's Limited
Sai Parenteral's Limited, a pharmaceutical formulations company, engages in the branded generic formulations and contract development and manufacturing businesses in India and internationally. Its portfolio includes formulation products across various therapeutic areas, such as cardiovascular, neuropsychiatry, anti-diabetic, respiratory health, antibiotics, gastroenterology, vitamins, minerals and supplements, analgesics, oncology, and dermatology in various dosage forms, including injectables, solid orals, liquid orals, and topicals. The company was founded in 1988 and is based in Hyderabad, India.
- Headquarters
- Hyderabad, India
- Employees
- 293
- Promoter Holding
- 74.83%
The full Sai Parenteral's Limited analysis
Create a free account to open the complete SAIPARENT deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.